Basit öğe kaydını göster

dc.contributor.authorŞahinli, Hayriye
dc.contributor.authorAkyürek, Nalan
dc.contributor.authorYılmaz, Mukaddes
dc.contributor.authorKandemir, Olcay
dc.contributor.authorOcak Duran, Ayşe
dc.contributor.authorKulaçoğlu, Sezer
dc.contributor.authorUçar, Gökhan
dc.contributor.authorAcar, Elif
dc.contributor.authorÖzet, Ahmet
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorÇakmak Öksüzoğlu, Ömür Berna
dc.contributor.authorYıldırım Özdemir, Nuriye
dc.date.accessioned2021-04-05T12:59:07Z
dc.date.available2021-04-05T12:59:07Z
dc.date.issued2021en_US
dc.identifier.citationŞahinli, H., Akyürek, N., Yılmaz, M., Kandemir, O., Ocak Duran, A., Kulaçoğlu, S. ... Yıldırım Özdemir, N. (2021). PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma. Indian Journal of Cancer, 58(4), 561-566. https://dx.doi.org/10.4103/ijc.IJC_459_19en_US
dc.identifier.issn0019-509X
dc.identifier.issn1998-4774
dc.identifier.urihttps://dx.doi.org/10.4103/ijc.IJC_459_19
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6696
dc.description.abstractBackground: Programmed death-ligand 1 (PD-L1) has been determined as a reliable prognostic factor for various malignancies. In this study, we aimed to determine the prognostic effect of PD-L1 expression in tumor-infiltrating immune cells (TIICs) of nasopharyngeal carcinoma (NPC) patients.Methods: Seventy patients diagnosed with non-metastatic NPC were included in the study. PD-L1 expression on immune cells was analyzed by immunohistochemical method. Patients were categorized into two groups according to the PD-L1 expression level in TIICs (level of PD-L1 staining ≥5% positive vs <5% negative).Results: Median follow-up period was 34 months (range = 1 - 188). 1 and 2 years survival rate were found as 75% and 63% in PD-L1 negative TIICs group (47%), and 85% and 83% in PD-L1 positive TIICs group (53%), respectively. PD-L1 positivity in immune cells (ICs) was detected in 53% of the patients. The survival rate was found better in the PD- L1 positive group compared to the negative group (P = 0.049).Discussion: In conclusion, the survival rate was found significantly better in the PD-L1 positive TIICs group, compared to the negative group.en_US
dc.language.isoengen_US
dc.publisherIndian Cancer Societyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectNasopharyngeal Carcinomaen_US
dc.subjectPrognosisen_US
dc.subjectProgrammed Death Ligand-1en_US
dc.titlePD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinomaen_US
dc.typearticleen_US
dc.relation.ispartofIndian Journal of Canceren_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume58en_US
dc.identifier.issue4en_US
dc.identifier.startpage561en_US
dc.identifier.endpage566en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.4103/ijc.IJC_459_19en_US
dc.identifier.scopusqualityQ3en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess